Chemotherapy shortage sparks small number of Alberta treatment delays cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
KEY POINTS
Infection with high-risk strains of the human papillomavirus (HPV) is a known prerequisite for developing cervical cancer.[1][1] Soon, a test for high-risk strains of HPV will replace the Papanicolaou (Pap) test for routine cervical cancer screening in Canada. Unlike the Pap test, which
GSK announced today that it has been granted Notice of Compliance with conditions for its endometrial cancer treatment JEMPERLI (dostarlimab for injection) by Health Canada. - Click here if this is your press release! - eTurboNews | Trends | Travel News